2025 STS Coronary Conference: Abstract Session IV

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

David Glineur, MD, PhD

Piroze Davierwala, MD
Disclosure(s): Medtronic: Speakers Bureau/Honoraria, Fellowship Support; Edwards Lifesciences: Fellowship Support

Presentations

  1. Applicability of the STS Risk-Adjusted Failure-to-Rescue Model in a Single UK Adult Cardiac Centre: A Step Toward Nationwide Implementation? 
    Augusta Paulikaite
     
  2. Association Between Preoperative Non-Tobacco Nicotine Dependence and Postoperative Complication Outcomes in Coronary Artery Bypass Graft Surgery
    Teerth Patel
     
  3. Making the Most Out of the Internal Mammary Artery: Does Sequential Grafting on the Left Anterior Descending Artery Territory Provide Clinical Benefits in a Bilateral Internal Mammary Artery Grafting Strategy? 
    Nassim Bousmaha, MD
     
  4. Time from STEMI to CABG Impacts Survival Outcomes 
    Joshua Crane, MD
     
  5. Age-Based Survival Benefit of Radial Artery in Coronary Artery Bypass Grafting 
    Trent Sherman
     
  6. Coronary Artery Bypass Grafting with Impella 5.5 Assist Device Support in Reduced Ejection Fraction: A Case Series 
    Massimo Baudo, MD
     
  7. Safety and Efficacy of Veno-Arterial ECMO Support in Robotic-Assisted Coronary Artery Bypass Grafting 
    Syed Peer, MD
     
  8. Does Robotic TECAB Mitigate the Risks of BITA Grafting in Insulin-Dependent Diabetic Patients? Early and Mid-Term Outcomes Compared to a Non-Diabetic Population 
    Riya Bhasin
     
  9. A Promising "Minimal-Volume" Cardioplegic Solution with Excellent Clinical Results
    Thierry Carrel-Dahinden, MD
    Discolsure(s): Novostia: Consultant/Advisory Board; Abbott Inc: Consultant/Advisory Board; SwissCardioTechnologies AG: Consultant/Advisory Board 
Activity summary
Available credit: 
  • 1.00 ABS Accredited CME
  • 1.00 ABTS Accredited CME
  • 1.00 AMA PRA Category 1 Credit
Activity opens: 
06/12/2025
Activity expires: 
06/30/2026
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 ABS Accredited CME
  • 1.00 ABTS Accredited CME
  • 1.00 AMA PRA Category 1 Credit

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

David Glineur, MD, PhD

Piroze Davierwala, MD
Disclosure(s): Medtronic: Speakers Bureau/Honoraria, Fellowship Support; Edwards Lifesciences: Fellowship Support

Presentations

  1. Applicability of the STS Risk-Adjusted Failure-to-Rescue Model in a Single UK Adult Cardiac Centre: A Step Toward Nationwide Implementation? 
    Augusta Paulikaite
     
  2. Association Between Preoperative Non-Tobacco Nicotine Dependence and Postoperative Complication Outcomes in Coronary Artery Bypass Graft Surgery
    Teerth Patel
     
  3. Making the Most Out of the Internal Mammary Artery: Does Sequential Grafting on the Left Anterior Descending Artery Territory Provide Clinical Benefits in a Bilateral Internal Mammary Artery Grafting Strategy? 
    Nassim Bousmaha, MD
     
  4. Time from STEMI to CABG Impacts Survival Outcomes 
    Joshua Crane, MD
     
  5. Age-Based Survival Benefit of Radial Artery in Coronary Artery Bypass Grafting 
    Trent Sherman
     
  6. Coronary Artery Bypass Grafting with Impella 5.5 Assist Device Support in Reduced Ejection Fraction: A Case Series 
    Massimo Baudo, MD
     
  7. Safety and Efficacy of Veno-Arterial ECMO Support in Robotic-Assisted Coronary Artery Bypass Grafting 
    Syed Peer, MD
     
  8. Does Robotic TECAB Mitigate the Risks of BITA Grafting in Insulin-Dependent Diabetic Patients? Early and Mid-Term Outcomes Compared to a Non-Diabetic Population 
    Riya Bhasin
     
  9. A Promising "Minimal-Volume" Cardioplegic Solution with Excellent Clinical Results
    Thierry Carrel-Dahinden, MD
    Discolsure(s): Novostia: Consultant/Advisory Board; Abbott Inc: Consultant/Advisory Board; SwissCardioTechnologies AG: Consultant/Advisory Board